Life Science
VRS Recruitment places research scientists, biochemists, antibody discovery specialists, and bioprocessing professionals into UK pharma, biotech, and biopharmaceutical employers. UCB is among the clients we place into. Our consultants come from life science research backgrounds and screen candidates on assay portfolio, not job title.
Where We Can Help
VRS Recruitment places research scientists, biochemists, antibody discovery specialists, and bioprocessing professionals into UK pharma, biotech, and biopharmaceutical employers. UCB is among the clients we place into. Our consultants come from life science research backgrounds and screen candidates on assay portfolio, not job title.
Specialized Recruitment
Job Titles
Industries
Employment Type
Techniques and Disciplines We Recruit Against
Life science recruitment runs on assay and technique fluency. VRS consultants ask which platforms the candidate has built, which targets they have validated, and which biological problems they have solved. The depth matters because a phage display antibody scientist is a different hire to a hybridoma immunisation scientist, even when both CVs read 'antibody discovery'.
Which antibody discovery and protein techniques does VRS recruit for?
Phage display, yeast display, hybridoma, transgenic platforms, antibody engineering, and antibody optimisation. Protein science covers expression (E. coli, mammalian, baculovirus), purification (AKTA, HPLC, SPR-driven affinity work), and characterisation (SPR, ITC, AUC, BLi, biophysical methods). Biophysics specialists across SPR, ITC, and AUC sit on the same desk.
Beyond antibody work, which other life science disciplines are in scope?
Cell biology and in vitro pharmacology (FRET, HTRF, high-content imaging, plate readers, automated platforms), genomics and transcriptomics (PCR, qPCR, NGS, bioinformatics), tissue work (IHC, RNAscope, organoid models), DMPK and PK/PD, and bioprocessing across upstream and downstream processing including fermentation and bioreactor scale-up
Job Titles VRS Places
Placements run from research associate through to head-of-biology and chief scientific officer appointments. Common titles include research associate, research scientist, senior research scientist, principal scientist, group leader, head of biology, head of antibody discovery, head of protein science, head of bioprocessing, and chief scientific officer for retained search.
Does VRS recruit research associates and graduate scientists?
Yes. Research associate hiring runs through both direct placements and our PhD-to-industry pipeline. The careers for PhD graduates resource on our blog covers the academic-to-industry transition. Research associate placements typically settle within four to six weeks for common technique stacks, longer for specialist platforms.
Which life science contract assignments come through VRS?
Maternity and paternity cover across research scientist roles, project-based antibody discovery work attached to specific target programmes, bioprocessing scale-up support during clinical study progression, and short-term consultancy from senior scientists supporting due diligence or platform reviews. Contract demand is consistent across UK biopharma.
Industries and Where the Demand Sits
Biopharmaceutical research drives the largest share of VRS life science placements, followed by mid-cap biotech and early-stage spin-outs scaling from university IP. The UK life science map clusters around Cambridge, Oxford, Stevenage (the GSK and Wellcome corridor), Macclesfield (AstraZeneca), Edinburgh and Dundee (genomics and translational research), and the Mersey-Cheshire pharma corridor.
Which UK life science clusters hire the most?
Cambridge leads on biotech and early-stage drug discovery. Oxford and the Stevenage corridor lead on biopharmaceutical research at scale. Macclesfield concentrates pharma R&D. Edinburgh and Dundee hold genomics, translational research, and protein science specialisms. Manchester anchors contract research and bioanalysis.
How does early-stage biotech hiring differ from large pharma?
Early-stage biotech hiring weights towards platform-builders who can establish assays from scratch and work without functional support. Large pharma hiring weights towards specialists deepening existing platforms or applying validated methods at scale. Salary structures differ accordingly: biotech weights equity higher, pharma weights base salary and pension.
Common-technique permanent shortlists (cell biology, standard molecular biology, common antibody work) typically deliver in seven to ten working days. Specialist combinations (advanced protein engineering, niche bioprocessing platforms, head-of-discovery hires) require ten to fifteen working days. Retained executive search runs to a structured methodology with milestone-based delivery.